Research Areas

A Double-Blind Pilot Dose Ranging Study of an Investigational Medication Taken Once Daily Compared to Placebo and to Lovastatin Taken Once Daily in Patients With Hypercholesterolemia

Safety and Efficacy of an investigational medication in Patients with Type 2 Diabetes Using Thiazolidinediones or Thiazolidinediones and Metformin

A Multicenter, Randomized, Double-Blind, Active Controlled Study to Compare the Effect of 52 Weeks Treatment with an investigational medication to Metformin up to 1000 mg bid in Drug Naïve Patients with Type II Diabetes.

Randomized, Comparative Evaluation of the Efficacy and Safety of an Investigational Medication Versus Glipizide in Patients With Non-Insulin Dependent Diabetes Mellitus

Accupril Decision on Pharmacotherapy for Hypertension

Evaluation of an Investigational Medication Versus Placebo for Gallstone Prophylaxis During Very Low Calorie Diet-Induced Rapid Weight Loss

A 24-Week Randomized, Double-Blind, Multi-Center, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of an investigational Therapy When Added to Therapy of Patients with Type 2 Diabetes

A Phase II, Double-Blind, Randomized, Placebo-Controlled, Proof-of-Concept Study of the Efficacy, Safety, and Tolerability of Pioglitazone HCL (Actos) in Combination With an investigational medication in Subjects With Type 2 Diabetes

Effects of Mixture Therapies on the Overall Glycemic Control of Patients with Type 2 Diabetes: A Comparison of an investigational medication to Once-Daily Insulin Glargine Plus Lispro

A Placebo Controlled Phase II Study to Evaluate the Efficacy and Safety of Twelve-Week Treatment with Two Different Doses of an investigational medication, in Patients with Type 2 Diabetes Mellitus Treatment With Metformin

A Randomized, Double-Blind, Placebo-Controlled Trial to Assess Safety and Tolerability during Treatment of Type 2 Diabetes with Usual Diabetes Therapy and either investigational medication or Placebo

A Multi-Center, Double-Blind, Randomized, Placebo-Controlled Group Comparison Study to Investigate the Efficacy, Tolerability and Safety of Three Different Doses of an Investigational Medication in Patients With Non-Insulin-Dependent (Type II) Diabetes Mellitus, Treated With Diet Alone

Fifty-Six Week Open Label Study to Investigate the Long-Term Safety and Tolerability of an Investigational Medication in Patients with Non-Insulin Dependent (Type II) Diabetes Mellitus, Treated With Diet Alone

Randomized, Comparative Evaluation of an Investigational Medication Combined With Insulin Versus Insulin Combined With Placebo In The Treatment of Patients With Non-Insulin Dependent Diabetes Mellitus

Randomized Study Comparing Two Dose Levels of an Investigational Medication and Vehicle For An Investigational Topical Gel in the Treatment of Diabetic Patients With Neuropathic Plantar Ulcers

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of an Investigational Medication Compared with Ranitidine and GR88502X for the Prophylaxis of Nonsteroidal Anti-Inflammatory Drug-Associated Gastric or Duodenal Ulcers in Patients with Osteo- or Rheumatoid Arthritis and Without a History of Gastric or Duodenal Ulcers

A Double Blind Dose-Ranging Study of an Investigational Medication taken Once Daily Compared to Placebo and to Lovastatin Taken Once Daily in Patients with Hypercholesterolemia

Standard Training versus Intensive Training for an investigational medication and device in Insulin-Naïve Patients with Type 2 Diabetes Mellitus

A Multicenter, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of the Addition of an investigational medication to Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Pioglitazone Therapy

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of an investigational medication Monotherapy in Patients with Type 2 Diabetes Mellitus and Metabolic Syndrome